Skip to main content
  • Home
  • Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Topic:
  • Intervention
  • Structural Heart Disease

Available Credit:

  • 1 EBAC

Course Published On:

Course Expiry Date:

Overview

In this satellite symposium, 'Severe Aortic Stenosis: Stratifying Patients for Lifetime Management' hear from leading faculty as they consider when to use a surgery or TAVI-first approach, summarise clinical evidence to date and assess possible management scenarios by way of clinical cases.

This symposium is part of Transcatheter Interventions Online 2022, a world-class virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease.

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

This programme is supported by unrestricted educational grants from Edwards Lifesciences. The scientific programme has not been influenced in any way by the sponsors.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

The session of ‘Severe Aortic Stenosis: Stratifying Patients for Lifetime Management’ is accredited by the European Board for Accreditation in Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. 

Support Statement

This programme is supported by unrestricted educational grants from Edwards Lifesciences. The scientific programme has not been influenced in any way by the sponsors.

Instruction to Participants

There is no fee for taking part in this online learning activity.

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

To complete the course and claim certification participants must:

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • Interventional cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional cardiology nurses

Learning Objectives

The symposium, ‘Severe Aortic Stenosis: Stratifying Patients for Lifetime Management’, endeavours to best address the following learning objectives:

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
Register now Log in

Module

Title

Duration

Speakers

Session 1 Forward Planning in Severe AS David Wood (Vancouver General Hospital, Canada)
Session 2 SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us? Victoria Delgado (Germans Trias i Pujol Hospital, Barcelona)
Session 3 SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals? Rebecca T Hahn (Columbia University Irving Medical Center, New York)
Session 1.

Forward Planning in Severe AS

Duration:

Speakers: David Wood (Vancouver General Hospital, Canada)

Session 2.

SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us?

Duration:

Speakers: Victoria Delgado (Germans Trias i Pujol Hospital, Barcelona)

Session 3.

SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?

Duration:

Speakers: Rebecca T Hahn (Columbia University Irving Medical Center, New York)

Chair

Thomas Modine

CHRU de Lille, Lille, France

Thomas Modine graduated from Lille University Hospital, France. He has MD, PhD and MBA degrees and is a renowned surgeon in TAVI, TMVR, minimally invasive surgery and valve sparing techniques.

View full profile

Speaker

David Wood

Vancouver General Hospital

Dr David Wood works as an interventional cardiologist at Vancouver General Hospital.

Dr Wood is a professor in the Department of Medicine at the University of British Columbia and a co-founding member of the Centre for Heart Valve Innovation in Vancouver.

View full profile

Victoria Delgado

Germans Trias i Pujol Hospital, Barcelona (Spain)

Dr Victoria Delgado is a board certified cardiologist with specific expertise in multimodality imaging, Assistant professor of Cardiology at the Leiden University Medical Center.

View full profile

Rebecca T Hahn

New York Presbyterian Hospital/Columbia University Medical Center, New York, NY, US; Cardiovascular Research Foundation, New York, NY, US

Rebecca T Hahn is Director of Interventional Echocardiography at NewYork-Presbyterian/ Columbia University Medical Center, US. She also serves as Professor of Clinical Medicine at Columbia College of Physicians and Surgeons.

View full profile

1.00 European Board for Accreditation in Cardiology (EBAC)

Related Courses

Renal Denervation In The Real World: Practical Guidance For New Users
  • 1 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
Transcatheter Interventions Online - Session 3.4: Debates
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.2: Strategies For Calcified Coronary Lesions Anno 2022: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.1: Strategies For Calcified Coronary Lesions Anno 2022
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more